Page last updated: 2024-10-20

quinolinic acid and Disease Exacerbation

quinolinic acid has been researched along with Disease Exacerbation in 15 studies

Quinolinic Acid: A metabolite of tryptophan with a possible role in neurodegenerative disorders. Elevated CSF levels of quinolinic acid are correlated with the severity of neuropsychological deficits in patients who have AIDS.
pyridinedicarboxylic acid : Any member of the class of pyridines carrying two carboxy groups.
quinolinic acid : A pyridinedicarboxylic acid that is pyridine substituted by carboxy groups at positions 2 and 3. It is a metabolite of tryptophan.

Research Excerpts

ExcerptRelevanceReference
"The aim of this paper is to elucidate the role of oxidative and nitrosative stress as well as the tryptophan catabolites pathway in the development of depression and the mechanism of action of antidepressant drugs, based on the available literature."8.95Oxidative and Nitrosative Stress as Well as the Tryptophan Catabolites Pathway in Depressive Disorders. ( Czarny, P; Galecki, P; Sliwinski, T; Wigner, P, 2017)
"The aim of this paper is to elucidate the role of oxidative and nitrosative stress as well as the tryptophan catabolites pathway in the development of depression and the mechanism of action of antidepressant drugs, based on the available literature."4.95Oxidative and Nitrosative Stress as Well as the Tryptophan Catabolites Pathway in Depressive Disorders. ( Czarny, P; Galecki, P; Sliwinski, T; Wigner, P, 2017)
"Increased oxidative stress (SOX), inflammation and accelerated atherosclerosis have been reported in end-stage renal disease (ESRD), but their associations with kynurenine pathway activation remain unknown."3.75Kynurenine, quinolinic acid--the new factors linked to carotid atherosclerosis in patients with end-stage renal disease. ( Brzosko, S; Mysliwiec, M; Pawlak, D; Pawlak, K, 2009)
"These are astrocytosis, up-regulation of mRNA encoding the neuropeptide somatostatin (SRIF) and an increased expression of MHC Class II antigen."2.39Neuronal substrates for SIV encephalopathy. ( da Cunha, A; Eiden, LE; Rausch, DM, 1994)
"Disease progression was evaluated by virological assessment of blood and cerebral spinal fluid (CSF), CD4 T cell count in blood, and quinolinic acid levels in CSF (a surrogate marker of neuronal cell damage)."1.32HIV in central nervous system and behavioral development: an HIV-2287 macaque model of AIDS. ( Anderson, BD; Anderson, DM; Bielefeldt-Ohmann, H; Ho, RJ; Hu, SL; Kinman, LM; Leigh, J; Morton, WR; Worlein, JM, 2004)

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (13.33)18.2507
2000's7 (46.67)29.6817
2010's6 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Robertson, DS1
Wigner, P1
Czarny, P1
Galecki, P1
Sliwinski, T1
Botticelli, A1
Cerbelli, B1
Lionetto, L2
Zizzari, I1
Salati, M1
Pisano, A1
Federica, M1
Simmaco, M2
Nuti, M1
Marchetti, P1
Curto, M1
Fazio, F1
Corigliano, V1
Comparelli, A1
Ferracuti, S1
Nicoletti, F1
Baldessarini, RJ1
van der Sluijs, KF1
van de Pol, MA1
Kulik, W1
Dijkhuis, A1
Smids, BS1
van Eijk, HW1
Karlas, JA1
Molenkamp, R1
Wolthers, KC1
Johnston, SL1
van der Zee, JS1
Sterk, PJ1
Lutter, R1
Pawlak, K1
Brzosko, S1
Mysliwiec, M1
Pawlak, D1
Graham, RK1
Pouladi, MA1
Joshi, P1
Lu, G1
Deng, Y1
Wu, NP1
Figueroa, BE1
Metzler, M1
André, VM1
Slow, EJ1
Raymond, L1
Friedlander, R1
Levine, MS1
Leavitt, BR1
Hayden, MR1
Xifró, X1
Giralt, A1
Saavedra, A1
García-Martínez, JM1
Díaz-Hernández, M1
Lucas, JJ1
Alberch, J1
Pérez-Navarro, E1
Lee, ST1
Chu, K1
Jung, KH1
Im, WS1
Park, JE1
Lim, HC1
Won, CH1
Shin, SH1
Lee, SK1
Kim, M1
Roh, JK1
Nair, MP1
Samikkannu, T1
Medana, IM1
Day, NP1
Salahifar-Sabet, H1
Stocker, R1
Smythe, G1
Bwanaisa, L1
Njobvu, A1
Kayira, K1
Turner, GD1
Taylor, TE1
Hunt, NH1
Kinman, LM1
Worlein, JM1
Leigh, J1
Bielefeldt-Ohmann, H1
Anderson, DM1
Hu, SL1
Morton, WR1
Anderson, BD1
Ho, RJ1
Ramaswamy, S1
McBride, JL1
Kordower, JH1
da Cunha, A1
Eiden, LE1
Rausch, DM1
Misztal, M1
Skangiel-Kramska, J1
Niewiadomska, G1
Danysz, W1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
An MRI Ancillary Study of a Malaria Fever Randomized Controlled Trial (RCT)[NCT05746819]256 participants (Anticipated)Observational2021-01-02Enrolling by invitation
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

4 reviews available for quinolinic acid and Disease Exacerbation

ArticleYear
Oxidative and Nitrosative Stress as Well as the Tryptophan Catabolites Pathway in Depressive Disorders.
    Psychiatria Danubina, 2017, Volume: 29, Issue:4

    Topics: Antidepressive Agents; Antioxidants; Biomarkers; Depression; Depressive Disorder; Disease Progressio

2017
Differential regulation of neurotoxin in HIV clades: role of cocaine and methamphetamine.
    Current HIV research, 2012, Volume: 10, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; AIDS Dementia Complex; Arachidonic Acid; Central Nervous System

2012
Animal models of Huntington's disease.
    ILAR journal, 2007, Volume: 48, Issue:4

    Topics: Animals; Disease Models, Animal; Disease Progression; Genetic Vectors; Huntington Disease; Lentiviru

2007
Neuronal substrates for SIV encephalopathy.
    Advances in neuroimmunology, 1994, Volume: 4, Issue:3

    Topics: Animals; Astrocytes; Cognition Disorders; Disease Progression; Encephalitis, Viral; Gene Expression

1994

Trials

1 trial available for quinolinic acid and Disease Exacerbation

ArticleYear
Metabolites of the kynurenine pathway of tryptophan metabolism in the cerebrospinal fluid of Malawian children with malaria.
    The Journal of infectious diseases, 2003, Sep-15, Volume: 188, Issue:6

    Topics: Adult; Child; Child, Preschool; Disease Progression; Humans; Kynurenine; Malaria, Cerebral; Malawi;

2003

Other Studies

10 other studies available for quinolinic acid and Disease Exacerbation

ArticleYear
Proposed biochemistry of Parkinson's and Alzheimer's diseases.
    Medical hypotheses, 2017, Volume: 109

    Topics: Aldehydes; Alzheimer Disease; Aspartic Acid; Betaine; Brain; Disease Progression; Humans; Kynurenine

2017
Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC?
    Journal of translational medicine, 2018, 08-06, Volume: 16, Issue:1

    Topics: Aged; Carcinoma, Non-Small-Cell Lung; Disease Progression; Drug Resistance, Neoplasm; Female; Humans

2018
Serum xanthurenic acid levels: Reduced in subjects at ultra high risk for psychosis.
    Schizophrenia research, 2019, Volume: 208

    Topics: Adolescent; Adult; Disease Progression; Female; Humans; Hydroxyindoleacetic Acid; Kynurenic Acid; Ky

2019
Systemic tryptophan and kynurenine catabolite levels relate to severity of rhinovirus-induced asthma exacerbation: a prospective study with a parallel-group design.
    Thorax, 2013, Volume: 68, Issue:12

    Topics: Adult; Asthma; Biomarkers; Breath Tests; Bronchoalveolar Lavage Fluid; Case-Control Studies; Cytokin

2013
Kynurenine, quinolinic acid--the new factors linked to carotid atherosclerosis in patients with end-stage renal disease.
    Atherosclerosis, 2009, Volume: 204, Issue:2

    Topics: Adult; Age Factors; Biomarkers; C-Reactive Protein; Carotid Artery Diseases; Cross-Sectional Studies

2009
Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2009, Feb-18, Volume: 29, Issue:7

    Topics: Animals; Brain; Brain Ischemia; Cells, Cultured; Dendritic Spines; Disease Models, Animal; Disease P

2009
Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington's disease: role in excitotoxicity.
    Neurobiology of disease, 2009, Volume: 36, Issue:3

    Topics: Adult; Aged; Animals; Brain; Brain-Derived Neurotrophic Factor; Calcineurin; Calcineurin Inhibitors;

2009
Slowed progression in models of Huntington disease by adipose stem cell transplantation.
    Annals of neurology, 2009, Volume: 66, Issue:5

    Topics: Adipocytes; Animals; Cell Line, Tumor; Cells, Cultured; Corpus Striatum; Culture Media, Conditioned;

2009
HIV in central nervous system and behavioral development: an HIV-2287 macaque model of AIDS.
    AIDS (London, England), 2004, Jul-02, Volume: 18, Issue:10

    Topics: AIDS Dementia Complex; Analysis of Variance; Animals; Behavior, Animal; Cognition; Disease Progressi

2004
Subchronic intraventricular infusion of quinolinic acid produces working memory impairment--a model of progressive excitotoxicity.
    Neuropharmacology, 1996, Volume: 35, Issue:4

    Topics: Alzheimer Disease; Animals; Cerebral Ventricles; Disease Models, Animal; Disease Progression; Drug A

1996